Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
4D Molecular Therapeutics Inc (FDMT)
4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Astellas and 4D Molecular Therapeutics (4DMT) Enter into License Agreement to Use 4DMT's Proprietary Intravitreal R100 Vector for Rare Ophthalmic Targets PR Newswire - Mon Jul 10, 6:30PM CDT

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") and 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) (CEO: David...

FDMT : 12.31 (-0.24%)
2 Biotech Stocks to Buy, 1 to Sell Now stocknews.com - Wed Jun 28, 12:31PM CDT

The biotech industry is well-positioned for long-term growth thanks to increasing demand for quality healthcare, a rapidly aging population, and rising chronic diseases. Therefore, buying fundamentally...

FDMT : 12.31 (-0.24%)
PRQR : 1.3700 (+1.48%)
TRDA : 12.72 (+1.76%)
Wall Street - NYSE Full View
Markets Today: Stocks Higher as Bond Yields Fall on Jobless Claims Surge Barchart - Thu Jun 8, 8:05AM CDT

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.03%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.16%. U.S. stock index futures this morning recovered from overnight...

ESZ23 : 4,567.50 (+0.10%)
NQZ23 : 16,068.75 (+0.13%)
SMTC : 16.40 (+0.12%)
ADBE : 623.32 (+0.65%)
ALV : 100.92 (-0.63%)
IGT : 26.51 (+0.76%)
REVG : 15.33 (unch)
TCOM : 35.40 (-0.34%)
FDMT : 12.31 (-0.24%)
SIG : 81.22 (+0.35%)
OXM : 93.56 (-1.67%)
SMAR : 41.76 (+0.19%)
Wall Street - shutterstock_94127350
Stocks Little Changed Before the Open as Investors Weigh Interest Rate Outlook Barchart - Thu Jun 8, 4:31AM CDT

June S&P 500 futures (ESM23) are up +0.05%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.15% this morning after three major U.S. benchmark indices finished the regular session mixed as an unexpected...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CPB : 40.44 (-0.96%)
MCHP : 81.82 (+0.07%)
NXPI : 200.03 (+0.19%)
WBD : 10.62 (-1.48%)
WIZZ.LN : 1,848.000 (-1.36%)
GME : 13.49 (+13.27%)
HCP : 21.29 (+1.43%)
EXPI : 12.65 (+3.86%)
CURV : 3.84 (+1.05%)
FDMT : 12.31 (-0.24%)
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates Zacks - Wed May 10, 4:55PM CDT

4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of 0% and 79.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FDMT : 12.31 (-0.24%)
MRNS : 6.31 (+0.16%)
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 7:25AM CDT

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 60% and 27.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SPPI : 1.0300 (unch)
FDMT : 12.31 (-0.24%)
4D Molecular Therapeutics, Inc. (FDMT) Surges 5.4%: Is This an Indication of Further Gains? Zacks - Mon May 8, 5:27AM CDT

4D Molecular Therapeutics, Inc. (FDMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further...

FDMT : 12.31 (-0.24%)
NOTV : 2.60 (+6.12%)
4D Molecular Therapeutics, Inc. (FDMT) Soars 11.2%: Is Further Upside Left in the Stock? Zacks - Fri Apr 14, 3:23AM CDT

4D Molecular Therapeutics, Inc. (FDMT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further...

FDMT : 12.31 (-0.24%)
TBPH : 10.38 (-1.14%)
4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Lags Revenue Estimates Zacks - Wed Mar 15, 4:45PM CDT

4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of -12% and 74.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

FDMT : 12.31 (-0.24%)
BVS : 4.01 (-0.50%)
Durect (DRRX) Reports Q4 Loss, Tops Revenue Estimates Zacks - Tue Mar 7, 4:35PM CST

Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

DRRX : 0.6230 (-5.46%)
FDMT : 12.31 (-0.24%)

Barchart Exclusives

1 Small-Cap Semiconductor Stock to Buy for a 2024 Breakout Barchart - Tue Nov 28, 2:27PM CST
Everyone knows the mega-cap players in the chip game by now - but here's a look under the hood at one Russell 2000 semiconductor stock that's well-positioned for major upside in the year ahead, according to Wall Street. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot